ID
36094
Beskrivning
Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the Dosing Details form. It has to be filled in for all sessions each for day 1.
Nyckelord
Versioner (1)
- 2019-04-15 2019-04-15 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
15 april 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198
Similar models
Dosing Details
- StudyEvent: ODM
C0040223 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C2826892 (UMLS CUI [1,3])
C0806914 (UMLS CUI [2,1])
C2826892 (UMLS CUI [2,2])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])